Study of Interventional Pulmonologic Treatment of Benign Central Airway Fibrotic Stricture
Prospective, Randomized, Open, Controlled, Multicenter Stucy of Interventional Pulmonologic Treatment of Benign Central Airway Fibrotic Stricture
Sponsor: Changhai Hospital
This NA trial investigates Obstructive Airway Disease and is currently ongoing. Changhai Hospital leads this study, which shows 6 recorded versions since 2014 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Unknown NA
-
Jul 2024 — Sep 2024 [monthly]
Unknown NA
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status NA
-
Jun 2018 — Jan 2021 [monthly]
Unknown Status NA
-
Feb 2018 — Jun 2018 [monthly]
Unknown Status NA
Status: Not Yet Recruiting → Unknown Status
▶ Show 1 earlier version
-
Jan 2017 — Feb 2018 [monthly]
Not Yet Recruiting NA
First recorded
Dec 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Changhai Hospital
- China Meitan General Hospital
- Micro-Tech (Nanjing) Co., Ltd.
- Tang-Du Hospital
- The First Affiliated Hospital of Guangzhou Medical University
- Xinqiao Hospital of Chongqing
For direct contact, visit the study record on ClinicalTrials.gov .